Skip to Main Content
Services Talent Knowledge
Site Search


Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

March 27, 2020

COVID-19: President Trump Signs $2.2 Trillion Economic Stimulus Package

Today, President Trump signed Phase 3 of a series of bills responsive to the COVID-19 crisis. This phase, HR 784, known as the Coronavirus Aid, Relief, and Economic Security Act (CARES Act)—expands upon the prior relief by providing greater assistance to individuals, small businesses, state and local governments, tribal governments, and key industries impacted by COVID-19 (e.g., hospitals and airlines). It is unprecedented in size as well as scope and seeks to flood the economy with capital during this ever-evolving public health crisis.

This legislation is merely one piece of the regulatory, legislative, and other governmental developments being issued in response to the ongoing COVID-19 pandemic, all of which are moving rapidly at the federal, state, and local level and remain fluid. Barclay Damon has therefore assembled a team of practitioners across disciplines to track these developments and provide advice and counsel on what they mean to our clients.

Barclay Damon’s attorneys are actively assessing COVID-19 related regulatory, legislative, and other governmental developments and are prepared to assist clients in determining what each one means. We have set up a special page on our website where you can learn more about our team and access key legal alerts concerning COVID-19 developments.

If you have any questions regarding the content of this alert, please contact Yvonne Hennessey, partner, at, or any member of the firm’s COVID-19 Response Team at


Click here to sign up for alerts, blog posts, and firm news.

Featured Media


Second Department Finds Transcripts of Lack of Appearance for EUOs Not Admissible as Business Records


Important Developments From the Most Recent NYS Cannabis Control Board Meeting


Mandatory Proof of Vaccination and Use of ArriveCAN to Enter Canada to End on September 30, 2022. Will the United States Follow Suit?


NYS Submits 1115 Waiver Amendment (Health Equity Reform) to CMS


Federal Court Sanctions Party Where Corporate Representative Answered "I Don't Know" over 100 Times During 30(b)(6) Deposition


COVID-19 Business Interruption Update: Second Circuit Issues Decisions in Favor of Insurers Dismissing Claims

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out